Traditional IT zero trust architectures often fail in industrial settings due to the need to keep data on-premises for low latency response, the thousands of IoT devices requiring agentless ...
Alto Neuroscience (NYSE:ANRO) shares nosedived 66% Wednesday morning, the first trading session, after the company announced its psychiatric drug ALTO-100 had failed a key clinical study. After ...